PNPLA2 and Glucose intolerance: In conclusion, our findings support a novel mechanism by which CIDEC maintains adipose tissue homeostasis by regulating the lipolytic activity of the rate-limiting enzyme ATGL, thus reducing HFD-induced lipotoxicity and glucose intolerance.